[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]

G Ital Cardiol (Rome). 2017 Feb;18(2 Suppl 1):35S-36S. doi: 10.1714/2657.27247.
[Article in Italian]
No abstract available

MeSH terms

  • Cardiology
  • Excipients
  • Humans
  • Italy
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / pharmacokinetics*
  • Societies, Medical
  • Therapeutic Equivalency
  • Tirofiban / adverse effects
  • Tirofiban / pharmacokinetics*

Substances

  • Excipients
  • Platelet Aggregation Inhibitors
  • Tirofiban